Oral Abstract
Improving survival following pediatric kidney transplant

|
Room: MOA 6
Track: N/A

Presentations

Dechu Puliyanda, United States
Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case series

Zachary Oatley, United States
Tolerating Unfavorable Donor Criteria in Pediatric Kidney Transplantation: A Retrospective UNOS Analysis

Priya Verghese, United States
Low-Density Lipoprotein Apheresis for Recurrent Nephrotic Syndrome in Pediatric Kidney Recipients: A Systematic Review and Meta-Analysis

Binnaz Handan Ozdemir, Turkey
Age-dependent differences in pediatric versus adult kidney transplantation: ımpaired VEGF and NO signaling weaken microvascular ıntegrity and threaten renal graft survival

Dr. Agnieszka Swiatecka-Urban, United States
Risk stratification of chronic kidney allograft failure in donor-recipient (D-R) pairs

Dr. Yonghua Feng, People's Republic of China
Genetic Screening and Prognosis of Pediatric Patients with Primary Nephrotic Syndrome after Renal Transplantation

Mr. Nicos Kessaris, United Kingdom
Long-term Outcomes of Paediatric Kidney Transplants from DCD donors are comparable to those from DBD donors: a 33-year Comparative OPTN study

Mr. Nicos Kessaris, United Kingdom
Long-term outcomes of right versus left kidney transplants over a 33-year period in the USA – a comparative study

Dr. Longshan Liu, People's Republic of China
Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipients

Email: info@ipta2025.org
514-874-1717